Find a Tender
active
Official procurement procedure
Untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viruses
Design and execution of research and development
Laboratory services
Research and experimental development services
+1 more
Published value
£180,000
Submission deadline 10 Nov 2022, 12:00 GMT
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: CELL THERAPY CATAPULT LIMITED: "Untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viruses". Published status: active. Published value: £180,000. 1 published lot. Recorded submission deadline: 10 Nov 2022, 12:00 GMT. See the official notice for participation instructions.
| Contracting Authority | CELL THERAPY CATAPULT LIMITED | Scope & Categories | Not published | Submission Window | Closed 10 Nov 2022, 12:00 GMT |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £180,000 |
Bidder Intelligence · Authority Profile: CELL THERAPY CATAPULT LIMITED
Market Analytics
Derived from OCDS awards & bid statistics
Published history for CELL THERAPY CATAPULT LIMITED. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
2.8Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 4 active published awards; 4 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityCELL THERAPY CATAPULT LIMITED | Procedure methodNot published | Procurement categoryNot published |
Statusactive | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published10 Oct 2022, 11:06 BST | Last source update10 Oct 2022, 11:06 BST | Recurring procurementNo |
ClassificationDesign and execution of research and development, Laboratory services, Research and experimental development services, Research laboratory services | ||
Delivery area | ||
OCIDocds-h6vhtk-037448 | ||
What is being bought
Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV).
Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded.
A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3".
Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.
What changed
From the official release history
- Published value updated to £180,000
10 Oct 2022, 11:06 BST - Status changed to active
10 Oct 2022, 11:06 BST - Official notice release published
10 Oct 2022, 11:06 BST - Submission deadline changed to 10 Nov 2022, 12:00 GMT
10 Oct 2022, 11:06 BST - Buyer information updated
10 Oct 2022, 11:06 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedactivePublished value£180,000Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV). Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3". Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
10 Oct 2022, 11:06 BST - Submission deadline
10 Nov 2022, 12:00 GMT
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
CELL THERAPY CATAPULT LIMITED
Contracting authority GB-COH-10016023Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published